AKT1 and Cognitive impairment: Collectively, these molecular mechanisms suggest that CGEF may protect against CSR-induced cognitive impairment by activating the PI3K/AKT/GSK3Β pathway and upregulating neuroprotective proteins, ultimately enhancing synaptic function and neuronal plasticity.